Company Analysis
Sign in

Lantheus Holdings, Inc. (LNTH)

Nasdaq: LNTH · In Vitro & In Vivo Diagnostic Substances · North Billerica, MA · filing with the SEC since 2014
Full chart Alerts Compare
Grade6.8
◀ Past 8.7● Present 7.1▶ Future 4.5
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

195 patents granted to the 12 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Lantheus Holdings, Inc.’s names, not what it holds today.

Patents granted
195
192 utility, 2 design, 1 reissue, 1976 to Dec 31, 2025
Granted in 2025
9
Against 11 in 2024 and 7 in 2023
Applications published
262
16 of them in 2025
Names they are printed under
12
a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals17
Medical technology13
Computer technology8
Organic fine chemistry4
Engines, pumps, turbines2
IT methods for management1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name12 counted
Lantheus Medical Imaging, Inc. a subsidiary
US, as the owner printed on each patent
67 granted
93 published
Progenics Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
65 granted
53 published
Molecular Insight Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
41 granted
48 published
EXINI Diagnostics AB a subsidiary
named as the applicant on its applications, in SE
0 granted
24 published
EXINI Diagnostics AB a subsidiary
SE, as the owner printed on each patent
16 granted
2 published
PSMA Development Company, LLC a subsidiary
US, as the owner printed on each patent
5 granted
11 published
Progenics Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
14 published
Molecular Insight Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
8 published
Lantheus Medical Imaging, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
7 published
Evergreen Discovery, LLC a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Exini Diagnostics Aktiebolag a subsidiary
SE, as the owner printed on each patent
1 granted
0 published
Progenics Pharmaceuticals (Nevada), Inc. a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Names not counted (4)
Life Molecular Imaging GmbH
Most of its patents print CH; this name counts in DE, GB, US. 0 granted and 7 published under it are not counted.
Life Molecular Imaging GmbH
Most of its patents print CH; this name counts in DE, GB, US. 3 granted and 0 published under it are not counted.
Aphelion LLC
Most of its patents print IL; this name counts in US. 1 granted and 1 published under it are not counted.
Life Molecular Imaging GmbH
Most of its patents print BM; this name counts in DE, GB, US. 1 granted and 1 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 16, 202512,500,008Pierceable plug for needleEngines, pumps, turbinesLantheus Medical Imaging, Inc.
Sep 30, 202512,431,246Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsMedical technologyProgenics Pharmaceuticals, Inc.
Sep 16, 202512,417,533Systems and methods for artificial intelligence-based image analysis for cancer assessmentMedical technologyEXINI Diagnostics AB
Sep 16, 202512,414,748Systems and methods for automated and interactive analysis of bone scan images for detection of metastasesMedical technologyEXINI Diagnostics AB
Jun 10, 202512,324,845Ligands for imaging cardiac innervationOrganic fine chemistryLantheus Medical Imaging, Inc.
May 13, 202512,296,029Lipid-encapsulated gas microsphere compositions and related methodsPharmaceuticalsLantheus Medical Imaging, Inc.
Mar 4, 202512,243,637Systems and methods for artificial intelligence-based image analysis for detection and characterization of lesionsMedical technologyEXINI Diagnostics AB
Mar 4, 202512,243,236Systems and methods for platform agnostic whole body image segmentationMedical technologyEXINI Diagnostics AB
Feb 11, 202512,224,067Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsMedical technologyProgenics Pharmaceuticals, Inc.
Dec 10, 202412,161,730Methods for making ultrasound contrast agentsPharmaceuticalsLantheus Medical Imaging, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 21, 20252025/0262334LIPID-ENCAPSULATED GAS MICROSPHERE COMPOSITIONS AND RELATED METHODSPharmaceuticalsLantheus Medical Imaging, Inc.
Jul 31, 20252025/0242063METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOFOrganic fine chemistryLantheus Medical Imaging, Inc.
Jun 19, 20252025/0195698GAS NANO/MICRO-BUBBLE COMPOSITIONS AND USES THEREOFPharmaceuticalsLantheus Medical Imaging, Inc.
Jun 12, 20252025/0191752SYSTEMS AND METHODS FOR AUTOMATED DETERMINATION OF A PROSTATE CANCER STAGING SCOREMedical technologyEXINI Diagnostics AB
Jun 12, 20252025/0186634METHODS OF TREATING SMALL CELL LUNG CANCERPharmaceuticalsEvergreen Discovery, LLC
May 29, 20252025/0171398COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTSOrganic fine chemistryLantheus Medical Imaging, Inc.
May 29, 20252025/0170283COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTSOrganic fine chemistryLantheus Medical Imaging, Inc.
May 29, 20252025/0170282COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTSOrganic fine chemistryLantheus Medical Imaging, Inc.
May 22, 20252025/0161500LIGANDS FOR IMAGING CARDIAC INNERVATIONOrganic fine chemistryLantheus Medical Imaging, Inc.
May 22, 20252025/0161499METHODS FOR MAKING ULTRASOUND CONTRAST AGENTSPharmaceuticalsLantheus Medical Imaging, Inc.
What it applied for, 2024 to 2025: Medical technology 9 · Pharmaceuticals 8 · Organic fine chemistry 6 · Computer technology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton LNTH · research, not advice